journal article·2018-12-01

Progress in ligand design for monolayer-protected nanoparticles for nanobio interfaces

Matthew D. Manning, Albert L. Kwansa, Thomas Oweida, James S. Peerless, Abhishek Singh, Yaroslava G. Yingling

Biointerphases· Volume 13· Issue 6
Publisher page

Abstract

Ligand-functionalized inorganic nanoparticles, also known as monolayer-protected nanoparticles, offer great potential as vehicles for in vivo delivery of drugs, genes, and other therapeutics. These nanoparticles offer highly customizable chemistries independent of the size, shape, and functionality imparted by the inorganic core. Their success as drug delivery agents depends on their interaction with three major classes of biomolecules: nucleic acids, proteins, and membranes. Here, the authors discuss recent advances and open questions in the field of nanoparticle ligand design for nanomedicine, with a focus on atomic-scale interactions with biomolecules. While the importance of charge and hydrophobicity of ligands for biocompatibility and cell internalization has been demonstrated, ligand length, flexibility, branchedness, and other properties also influence the properties of nanoparticles. However, a comprehensive understanding of ligand design principles lies in the cost associated with synthesizing and characterizing diverse ligand chemistries and the ability to carefully assess the structural integrity of biomolecules upon interactions with nanoparticles.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Materials Science and Engineering, North Carolina State University , 911 Partners Way, Engineering Building I, Raleigh, North Carolina 27695

Funding

National Science Foundation

References (76)

Show source-provided references
1. Nat. Rev. Drug Discov. · 2010 · 9 · 61510.1038/nrd2591 ↗
2. Biomed. Pharmacother. · 2018 · 97 · 152110.1016/j.biopha.2017.11.026 ↗
3. Nat. Rev. Drug Discov. · 2014 · 13 · 81310.1038/nrd4333 ↗
4. Nat. Biotechnol. · 2006 · 24 · 121110.1038/nbt1006-1211 ↗
5. J. Control. Release · 2016 · 224 · 8610.1016/j.jconrel.2016.01.008 ↗
6. Clin. Pharmacol. Ther. · 2008 · 83 · 76110.1038/sj.clpt.6100400 ↗
7. Grand View Research Inc.
8. J. Drug Deliv. · 2012 · 2012 · 110.1155/2012/389485 ↗
9. Nanomedicine: Drivers for Development and Possible Impacts
10. Biomaterials · 2014 · 35 · 870310.1016/j.biomaterials.2014.06.033 ↗
11. Interface Focus · 2016 · 6 · 2015008610.1098/rsfs.2015.0086 ↗
12. Nanoscale · 2015 · 7 · 1663110.1039/C5NR02970H ↗
13. Polymers · 2016 · 8 · 8310.3390/polym8030083 ↗
14. ACS Nano · 2016 · 10 · 813310.1021/acsnano.6b05536 ↗
15. Polym. Chem. · 2018 · 9 · 25910.1039/C7PY01603D ↗
16. New J. Chem. · 2016 · 40 · 487910.1039/C5NJ03720D ↗
17. Nat. Mater. · 2013 · 12 · 95810.1038/nmat3792 ↗
18. Chem. Rev. · 2017 · 117 · 1147610.1021/acs.chemrev.7b00194 ↗
19. Nanomedicine · 2015 · 11 · 189310.1016/j.nano.2015.07.015 ↗
20. ACS Nano · 2016 · 10 · 735110.1021/acsnano.5b08133 ↗
21. Comput. Mech. · 2014 · 53 · 51110.1007/s00466-013-0953-5 ↗
22. Biomaterials · 2014 · 35 · 846710.1016/j.biomaterials.2014.06.032 ↗
23. Bioconjug. Chem. · 2017 · 28 · 310.1021/acs.bioconjchem.6b00534 ↗
24. J. R. Soc. Interface · 2014 · 11 · 2014030110.1098/rsif.2014.0301 ↗
25. Small · 2014 · 10 · 251610.1002/smll.201303540 ↗
26. J. Am. Chem. Soc. · 2011 · 133 · 219210.1021/ja108154a ↗
27. Small · 2010 · 6 · 224610.1002/smll.201000463 ↗
28. Mol. Immunol. · 1995 · 32 · 19910.1016/0161-5890(94)00124-J ↗
29. Annu. Rev. Biochem. · 1992 · 61 · 105310.1146/annurev.bi.61.070192.005201 ↗
30. Nat. Rev. Genet. · 2014 · 15 · 54110.1038/nrg3763 ↗
31. Angew. Chem. Int. Ed. · 2008 · 47 · 138210.1002/anie.200703039 ↗
32. Adv. Drug Deliv. Rev. · 2005 · 57 · 217710.1016/j.addr.2005.09.017 ↗
33. Bioconjug. Chem. · 2013 · 24 · 48710.1021/bc300381s ↗
34. RSC Adv. · 2013 · 3 · 608510.1039/C3RA22739A ↗
35. ACS Nano · 2016 · 10 · 499710.1021/acsnano.6b01415 ↗
36. Acc. Chem. Res. · 2013 · 46 · 68110.1021/ar3000647 ↗
37. J. Am. Chem. Soc. · 2001 · 123 · 762610.1021/ja015556g ↗
38. J. Phys. Chem. B · 2007 · 111 · 301910.1021/jp067926z ↗
39. Phys. Rev. Lett. · 2005 · 95 · 22810110.1103/PhysRevLett.95.228101 ↗
40. Chem. Biol. Drug Des. · 2006 · 67 · 29710.1111/j.1747-0285.2006.00372.x ↗
41. Macromolecules · 2012 · 45 · 520810.1021/ma300308y ↗
42. ACS Nano · 2015 · 9 · 1237410.1021/acsnano.5b05684 ↗
43. ACS Nano · 2008 · 2 · 221310.1021/nn800507t ↗
44. Adv. Mater. · 2012 · 24 · 426110.1002/adma.201104891 ↗
45. Curr. Pharm. Des. · 2015 · 2110.2174/1381612821666150901103937 ↗
46. Langmuir · 2010 · 26 · 1733910.1021/la102762t ↗
47. Biointerphases · 2016 · 11 · 04B30510.1116/1.4966653 ↗
48. Bioconjug. Chem. · 2002 · 13 · 310.1021/bc015545c ↗
49. Mol. Ther. · 2014 · 22 · 107510.1038/mt.2014.30 ↗
50. Angew. Chem. Int. Ed. Engl. · 2015 · 54 · 656710.1002/anie.201411615 ↗
51. Langmuir · 2017 · 33 · 36110.1021/acs.langmuir.6b02937 ↗
52. Langmuir · 2017 · 33 · 1448010.1021/acs.langmuir.7b03544 ↗
53. Crit. Rev. Biochem. Mol. Biol. · 2009 · 44 · 26410.1080/10409230903193307 ↗
54. Langmuir · 2016 · 32 · 1013610.1021/acs.langmuir.6b02371 ↗
55. ACS Nano · 2012 · 6 · 123010.1021/nn2038862 ↗
56. J. Phys. Chem. A · 2014 · 118 · 584810.1021/jp411662c ↗
57. Langmuir · 2016 · 32 · 160110.1021/acs.langmuir.6b00035 ↗
58. Nat. Mater. · 2008 · 7 · 58810.1038/nmat2202 ↗
59. Trends Biotechnol. · 2017 · 35 · 25710.1016/j.tibtech.2016.08.011 ↗
60. J. Am. Chem. Soc. · 2012 · 134 · 213910.1021/ja2084338 ↗
61. Angew. Chem. Int. Ed. · 2013 · 52 · 1257210.1002/anie.201304465 ↗
62. Bioconjug. Chem. · 2017 · 28 · 256910.1021/acs.bioconjchem.7b00410 ↗
63. J. Phys. Chem. C · 2015 · 119 · 2217210.1021/acs.jpcc.5b05796 ↗
64. Langmuir · 2017 · 33 · 173210.1021/acs.langmuir.6b03988 ↗
65. Small · 2018 · 14 · 170398210.1002/smll.201703982 ↗
66. J. Phys. Conf. Ser. · 2017 · 921 · 01200210.1088/1742-6596/921/1/012002 ↗
67. Nanoscale · 2017 · 9 · 213810.1039/C6NR07022A ↗
68. Sci. Rep. · 2016 · 6 · 2678310.1038/srep26783 ↗
69. Nanoscale · 2018 · 10 · 125610.1039/C7NR08322J ↗
70. Nat. Nanotechnol. · 2016 · 11 · 37210.1038/nnano.2015.330 ↗
71. Colloids Surf. B: Biointerfaces · 2000 · 18 · 30110.1016/S0927-7765(99)00156-3 ↗
72. Nanomedicine · 2014 · 10 · 145310.1016/j.nano.2014.01.009 ↗
73. Nanoscale · 2014 · 6 · 278210.1039/c3nr05559k ↗
74. J. Phys. Chem. B · 2017 · 121 · 953210.1021/acs.jpcb.7b07492 ↗
75. Nat. Nanotechnol. · 2015 · 10 · 47210.1038/nnano.2015.47 ↗
76. Eng. Life Sci. · 2018 · 18 · 8410.1002/elsc.201700019 ↗